RecruitingPhase 1 / Phase 2NCT06546670
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Sponsor: Novartis Pharmaceuticals
Providence, RI · +8 more sites
2 recruiting sickle cell disease studies with a site in Providence, RI.
All trials in Providence, RI · All Sickle Cell Disease trials
Sponsor: Novartis Pharmaceuticals
Providence, RI · +8 more sites
Sponsor: American Thrombosis and Hemostasis Network
Providence, RI · +75 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.